Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 15/20 | 0.46 |
| ▸ | DPP4 | P27487 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31331652 | 0.94 | KDM1A (0.48) | KDM1AKDM4ETP53SSTR2PGR | |
| SCHEMBL31331889 | 0.90 | KDM1A (0.52) | KDM1A | |
| SCHEMBL31331682 | 0.89 | KDM1A (0.52) | KDM1A | |
| SCHEMBL31331935 | 0.87 | KDM1A (0.49) | KDM1ADPP4CYP3A4KDM4ETP53 | |
| SCHEMBL31331816 | 0.87 | KDM1A (0.54) | KDM1A | |
| SCHEMBL31331734 | 0.84 | KDM4E (0.41) | KDM1ACYP3A4KDM4ETP53SSTR2 | |
| SCHEMBL31331861 | 0.84 | KDM1A (0.54) | KDM1ASSTR2 | |
| SCHEMBL31331740 | 0.84 | KDM1A (0.54) | KDM1ASSTR2 | |
| SCHEMBL31331989 | 0.83 | KDM1A (0.48) | KDM1ACYP3A4SSTR2 | |
| SCHEMBL31331786 | 0.81 | KDM1A (0.55) | KDM1AKDM4ETP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119285613-A | Substituted quinoxaline and quinazolinone compounds and uses thereof | 河南中医药大学 | 2025-01-10 | — | — | CN | claimed |
| CN-119285613-A | Substituted quinoxaline and quinazolinone compounds and uses thereof | 河南中医药大学 | 2025-01-10 | — | — | CN | disclosed |